Novo Nordisk Pharmaceutical Industries, Lp drugs

3 results
  • ozempic - semaglutide injection, solution

    (Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Ozempic is used alongside diet and exercise to improve blood sugar in adults with type 2 diabetes. It also reduces the risk of serious cardiovascular events in those with established heart disease, and lowers the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
  • rybelsus - oral semaglutide tablet

    (Oral Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Ozempic is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It also reduces the risk of serious cardiovascular events—including CV death, heart attack, and stroke—in adults with type 2 diabetes at high cardiovascular risk.
  • wegovy - semaglutide injection, solution

    (Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Wegovy reduces risk of major cardiovascular events in adults with established CV disease and obesity or overweight. It reduces excess body weight long term in adults and patients aged 12 and older with obesity or overweight with comorbidities, and treats MASH with moderate to advanced liver fibrosis in adults.